November 15, 2022
1 min read
Health Canada has approved Johnson & Johnson Vision’s Acuvue Abiliti Overnight Therapeutic Lenses for Myopia Management, the company announced in a press release.
According to the release, the orthokeratology lenses are intended to be worn overnight and are designed to match a patient’s unique corneal shape and prescription to temporarily reshape the cornea. Health Canada approved the company’s Acuvue Abiliti 1-day Soft Therapeutic Lenses for Myopia Management in September 2021.
“Johnson & Johnson Vision is helping to address the dramatically increasing rates of myopia by bringing forward innovative products, services and solutions to help control the disease and give families a chance at better eye health in the future,” Chandra Mickles, OD, MS, FAAO, FSLS, North America professional education lead for myopia at Johnson & Johnson Vision, said in the release. “With Abiliti Overnight lenses and Abiliti 1-Day lenses, we are adding to our growing suite of Abiliti products to help change the trajectory of myopia.”
Providers can load refraction, iris diameter and corneal topography data into the FitAbiliti software for the appropriate lens design. The company reports a fitting success rate of 90%.
The Abiliti lenses, which will be available in both myopia management and myopia management for astigmatism designs, are now available in select parts of Canada, according to the release.